Skip to content

Clinical trials

Phase 2 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 2 Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20032
20042
20054
20063
20071
20082
20096
20104
20113
20123
20131
20142
20152
20166
20174
20188
20193
20205
20216
20223
20236
20247
20259
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Recruiting19
Terminated13
Active, not recruiting7
Unknown status7
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Pfizer5
Fundación GECP4
National Heart, Lung, and Blood Institute (NHLBI)4
Eli Lilly and Company3
Merck Sharp & Dohme LLC3
Sichuan Cancer Hospital and Research Institute3
Vertex Pharmaceuticals Incorporated3
Bastiaan Driehuys2
Cardeas Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases105
Respiratory Tract Diseases36
Lung Neoplasms17
Carcinoma, Non-Small-Cell Lung16
Pulmonary Disease, Chronic Obstructive15
Asthma12
Thoracic Neoplasms12
Fibrosis10
Neoplasms10
Bronchial Diseases9

Trials

Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.